Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01665118 · ClinicalTrials.gov registry record · NA

The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction

A NA study of Body Fat, sponsored by Cutera.

Completed
Registry status
NA
Development phase
44
Enrollment target
3
Study locations

NCT01665118: Completed NA study of Body Fat, sponsored by Cutera.

NCT01665118 is a NA study of Body Fat that has completed, run by Cutera. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01665118, a NA study of Body Fat, has completed, sponsored by Cutera.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
3
Study locations

Study Summary

The objective of this study is to evaluate the safety and efficacy of the Trusculpt (Radio Frequency) device in the reduction of thigh circumference.

Primary Outcome

Change in thigh circumference from baseline of the treated thigh compared to the non-treated contra-lateral side at 12 weeks post-final treatment.

Conditions Studied

Interventions

  • DEVICE Trusculpt (Radio Frequency) Device

Study Locations (3)

California

  • Cutera Research Center - Brisbane

New Jersey

  • New Jersey Plastic Surgery - Montclair

Tennessee

  • Nashville Center for Laser and Facial Surgery - Nashville

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2012-08
Est. Completion 2013-06
Phase NA
Cutera

37 total trials

What the finished NCT01665118 record still lists

NCT01665118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Body Fat appearing as the primary indexed condition, and to 1 intervention - of which Trusculpt (Radio Frequency) Device is the first listed.

NCT01665118 reports a single indexed study location in California, New Jersey, Tennessee.

Frequently Asked Questions

What is clinical trial NCT01665118 about?

NCT01665118 is a clinical study titled "The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction". The objective of this study is to evaluate the safety and efficacy of the Trusculpt (Radio Frequency) device in the reduction of thigh circumference.

What is the current status of trial NCT01665118?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2012-08. Estimated completion is 2013-06.

What conditions does trial NCT01665118 study?

This clinical trial studies the following conditions: Body Fat.

What interventions are being tested in trial NCT01665118?

The interventions under investigation include: Trusculpt (Radio Frequency) Device (DEVICE).

Who is sponsoring clinical trial NCT01665118?

This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01665118 being conducted?

This trial has 3 study locations across California, New Jersey, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Fat

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01665118's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01665118, the US trial registry maintained by the National Library of Medicine. NCT01665118 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.